Logo image of CTKB

CYTEK BIOSCIENCES INC (CTKB) Stock Analyst Earnings Estimates

NASDAQ:CTKB - Nasdaq - US23285D1090 - Common Stock - Currency: USD

5.12  -0.08 (-1.54%)

After market: 5.12 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
CTKB revenue by date.CTKB revenue by date.
128M
37.93%
164M
28.13%
193.015M
17.69%
207.02M
7.26%
223.99M
8.20%
249.77M
11.51%
EBITDA
YoY % growth
CTKB ebitda by date.CTKB ebitda by date.
10.64M
-25.59%
690K
-93.52%
-21.797M
-3,258.99%
22.219M
201.94%
28.989M
30.47%
40.849M
40.91%
EBIT
YoY % growth
CTKB ebit by date.CTKB ebit by date.
9.4M
-31.39%
-1.8M
-119.15%
-27.845M
-1,446.94%
-21.395M
23.16%
-14.808M
30.79%
-2.342M
84.19%
Operating Margin
CTKB operating margin by date.CTKB operating margin by date.
7.34%-1.10%-14.43%-10.33%-6.61%-0.94%
EPS
YoY % growth
CTKB eps by date.CTKB eps by date.
N/A0.14
27.68%
0.05
-65.00%
-0.07
-241.55%
0.00
97.06%
0.03
1,800.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.05
32.60%
-0.04
28.60%
-0.03
61.75%
0.00
-100.00%
0.06
15.38%
-0.03
14.29%
-0.02
50.00%
0.020.06
Revenue
Q2Q % growth
60.571M
4.01%
47.837M
6.64%
52.801M
13.27%
56.85M
10.39%
69.17M
14.20%
55.6M
16.23%
58.871M
11.50%
63.06M
10.92%
77.688M
12.31%
EBITDA
Q2Q % growth
13.199M
123.30%
1.756M
119.44%
4.158M
182.83%
6.112M
450.63%
15.559M
17.88%
3.576M
103.64%
5.082M
22.22%
8.131M
33.03%
16.531M
6.25%
EBIT
Q2Q % growth
2.825M
2,162.04%
-8.178M
23.81%
-6.03M
29.28%
-2.824M
33.53%
4.461M
57.91%
-7.585M
7.25%
-5.455M
9.54%
-1.177M
58.33%
7.001M
56.94%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.01
1,100.00%
-0.020.03165.36%
Q2 2024
Q2Q % growth
-0.08
-900.00%
-0.03-0.05-161.44%
Q1 2024
Q2Q % growth
-0.05 -0.04-0.01-22.55%
Q4 2023
Q2Q % growth
0.04
-33.33%
0.000.041,077.65%
Q3 2023
Q2Q % growth
0.00
-102.50%
0.03-0.03-103.27%
Q2 2023
Q2Q % growth
0.01
-66.67%
0.03-0.02-67.32%
Q1 2023
Q2Q % growth
0.00
-100.00%
0.03-0.03-100.00%
Q4 2022
Q2Q % growth
0.06
100.00%
0.050.0126.04%
Q3 2022
Q2Q % growth
0.04
100.00%
0.020.0296.08%
Q2 2022
Q2Q % growth
0.03 0.020.0176.44%
Q1 2022
Q2Q % growth
0.01 -0.010.02296.08%
Q4 2021
Q2Q % growth
0.03 0.030.0017.65%
Q3 2021
Q2Q % growth
0.02 0.020.00-15.95%
Q2 2021
Q2Q % growth
0.00 0.02-0.02-100.00%
CTKB Yearly EPS VS EstimatesCTKB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 -0.1 0.15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
51.5M
7.29%
51.71M-210K-0.41%
Q2 2024
Q2Q % growth
46.617M
-6.19%
50.517M-3.9M-7.72%
Q1 2024
Q2Q % growth
44.86M
20.96%
44.458M402K0.90%
Q4 2023
Q2Q % growth
58.233M
20.47%
57.714M519K0.90%
Q3 2023
Q2Q % growth
48M
18.58%
56.585M-8.585M-15.17%
Q2 2023
Q2Q % growth
49.693M
23.74%
46.627M3.066M6.58%
Q1 2023
Q2Q % growth
37.088M
5.78%
48.089M-11.001M-22.88%
Q4 2022
Q2Q % growth
48.34M
24.30%
51.225M-2.885M-5.63%
Q3 2022
Q2Q % growth
40.48M
17.74%
44.154M-3.674M-8.32%
Q2 2022
Q2Q % growth
40.16M
32.06%
40.422M-262K-0.65%
Q1 2022
Q2Q % growth
35.06M
44.46%
33.158M1.902M5.74%
Q4 2021
Q2Q % growth
38.89M 37.148M1.742M4.69%
Q3 2021
Q2Q % growth
34.38M 34.053M327K0.96%
Q2 2021
Q2Q % growth
30.41M 28.846M1.564M5.42%
Q1 2021
Q2Q % growth
24.27M
34.91%
%
CTKB Yearly Revenue VS EstimatesCTKB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-100% -100% -13.33% 15%
Revenue0% 0% -0.85% -0.55%